Concomitant type I IFN receptor-triggering of T cells and of DC is required to promote maximal modified vaccinia virus Ankara-induced T-cell expansion

European Journal of Immunology

Volumn 40, Issue 10, 2010, Pages 2769-2777

  Frenz, Theresa ^a   Waibler, Zoe ^a   Hofmann, Janin ^a,g   Hamdorf, Matthias ^a   Lantermann, Markus ^a   Reizis, Boris ^b   Tovey, Michaël G ^c   Aichele, Peter ^d   Sutter, Gerd ^a,e   Kalinke, Ulrich ^a,f  

^a PAUL EHRLICH INSTITUT   (Germany)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c CNRS   (France)

^d UNIVERSITY OF FREIBURG   (Germany)

^e UNIVERSITY OF MUNICH   (Germany)

^f INSTITUTE OF INFECTION IMMUNOLOGY   (Germany)

^g INSTITUTE OF EXPERIMENTAL IMMUNOLOGY   (Switzerland)

Author keywords

CD8+; Modified vaccinia virus Ankara; T cell expansion; Type I IFN

Indexed keywords

EPITOPE; GLYCOPROTEIN P 15095; INTERFERON RECEPTOR; MODIFIED VACCINIA VIRUS ANKARA 5T4 VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CELL SURVIVAL; CONTROLLED STUDY; DENDRITIC CELL; GENE DELETION; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VACCINIA VIRUS;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD11C; CD8-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; EPITOPES, T-LYMPHOCYTE; FLOW CYTOMETRY; GENETIC VECTORS; INTERFERON TYPE I; LYMPHOCYTE ACTIVATION; MICE; SIGNAL TRANSDUCTION; VACCINIA VIRUS;

EID: 77957159060     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201040453     Document Type: Article

References (48)

1. Stetson, D. B. and Medzhitov, R., Type I interferons in host defense. Immunity 2006. 25: 373-381.
2. Samuel, C. E., Antiviral actions of interferons. Clin. Microbiol. Rev. 2001. 14: 778-809.
3. Honda, K., Takaoka, A. and Taniguchi, T., Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors. Immunity 2006. 25: 349-360. (Pubitemid 44354220)
4. Barchet, W., Cella, M. and Colonna, M., Plasmacytoid dendritic cells - virus experts of innate immunity. Semin. Immunol. 2005. 17: 253-261.
5. Kumagai, Y., Takeuchi, O., Kato, H., Kumar, H., Matsui, K., Morii, E., Aozasa, K. et al., Alveolar macrophages are the primary interferon-alpha producer in pulmonary infection with RNA viruses. Immunity 2007. 27: 240-252.
6. Isaacs, A. and Lindenmann, J., Virus interference. I. The interferon. Proc. R Soc. Lond. B Biol. Sci. 1957. 147: 258-267.
7. Tough, D. F., Borrow, P. and Sprent, J., Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science 1996. 272: 1947-1950. (Pubitemid 26234507)
8. Biron, C. A., Interferons alpha and beta as immune regulators - a new look. Immunity 2001. 14: 661-664.
9. Kamphuis, E., Junt, T., Waibler, Z., Forster, R. and Kalinke, U., Type I interferons directly regulate lymphocyte recirculation and cause transient blood lymphopenia. Blood 2006. 108: 3253-3261.
10. Le Bon, A., Thompson, C., Kamphuis, E., Durand, V., Rossmann, C., Kalinke, U. and Tough, D. F., Cutting edge: enhancement of antibody responses through direct stimulation of B and T cells by type I IFN. J. Immunol. 2006. 176: 2074-2078.
11. Quigley, M., Huang, X. and Yang, Y., STAT1 signaling in CD8 T cells is required for their clonal expansion and memory formation following viral infection in vivo. J. Immunol. 2008. 180: 2158-2164.
12. Aichele, P., Unsoeld, H., Koschella, M., Schweier, O., Kalinke, U. and Vucikuja, S., CD8 T cells specific for lymphocytic choriomeningitis virus require type I IFN receptor for clonal expansion. J. Immunol. 2006. 176: 4525-4529.
13. Kaser, A., Nagata, S. and Tilg, H., Interferon alpha augments activation-induced T cell death by upregulation of Fas (CD95/APO-1) and Fas ligand expression. Cytokine 1999. 11: 736-743.
14. Bahl, K., Kim, S., Calcagno, C., Ghersi, D., Puzone, R., Celada, F., Selin, L. K. and Welsh, R. M., IFN-induced attrition of CD8 T cells in the presence or absence of cognate antigen during the early stages of viral infections. J. Immunol. 2006. 176: 4284-4295.
15. Alcami, A., Symons, J. A. and Smith, G. L., The vaccinia virus soluble alpha/beta interferon (IFN) receptor binds to the cell surface and protects cells from the antiviral effects of IFN. J. Virol. 2000. 74: 11230-11239.
16. Waibler, Z., Anzaghe, M., Frenz, T., Schwantes, A., Pohlmann, C., Ludwig, H. and Palomo-Otero, M., Vaccinia virus-mediated inhibition of type I interferon responses is a multifactorial process involving the soluble type I interferon receptor B18 and intracellular components. J. Virol. 2009. 83: 1563-1571.
17. Meyer, H., Sutter, G. and Mayr, A., Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence. J. Gen. Virol. 1991. 72: 1031-1038.
18. Blanchard, T. J., Alcami, A., Andrea, P. and Smith, G. L., Modified vaccinia virus Ankara undergoes limited replication in human cells and lacks several immunomodulatory proteins: implications for use as a human vaccine. J. Gen. Virol. 1998. 79: 1159-1167.
19. Sutter, G. and Moss, B., Nonreplicating vaccinia vector efficiently expresses recombinant genes. Proc. Natl. Acad. Sci. USA 1992. 89: 10847-10851.
20. Drexler, I., Staib, C. and Sutter, G., Modified vaccinia virus Ankara as antigen delivery system: how can we best use its potential? Curr. Opin. Biotechnol. 2004. 15: 506-512.
21. Rimmelzwaan, G. F. and Sutter, G., Candidate influenza vaccines based on recombinant modified vaccinia virus Ankara. Expert Rev. Vaccines 2009. 8: 447-454.
22. Havenar-Daughton, C., Kolumam, G. A. and Murali-Krishna, K., Cutting edge: the direct action of type I IFN on CD4 T cells is critical for sustaining clonal expansion in response to a viral but not a bacterial infection. J. Immunol. 2006. 176: 3315-3319.
23. Kolumam, G. A., Thomas, S., Thompson, L. J., Sprent, J. and Murali-Krishna, K., Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J. Exp. Med. 2005. 202: 637-650.
24. Curtsinger, J. M., Valenzuela, J. O., Agarwal, P., Lins, D. and Mescher, M. F., Type I IFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation. J. Immunol. 2005. 174: 4465-4469.
25. + T cell determinants to enable rational design and characterization of smallpox vaccines. J. Exp. Med. 2005. 201: 95-104.
26. Sheehan, K. C. F., Lai, K. S., Dunn, G. P., Bruce, A. T., Diamond, M. S., Heutel, J. D. and Dungo-Arthur, C., Blocking monoclonal antibodies specific for mouse IFN-alpha/beta receptor subunit 1 (IFNAR-1) frommice immunized by in vivo hydrodynamic transfection. J Interferon Cytokine Res. 2006. 26: 804-819.
27. Prinz, M., Schmidt, H., Mildner, A., Knobeloch, K. P., Hanisch, U. K., Raasch, J., Merkler, D. et al., Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system. Immunity 2008. 28: 675-686.
28. Stockinger, S., Kastner, R., Kernbauer, E., Pilz, A., Westermayer, S., Reutterer, B. and Soulat, D., Characterization of the interferon-producing cell in mice infected with Listeria monocytogenes. PLoS Pathog 2009. 5: e1000355.
29. Liu, L., Chavan, R. and Feinberg, M. B., Dendritic cells are preferentially targeted among hematolymphocytes by modified vaccinia virus ankara and play a key role in the induction of virus-specific T cell responses in vivo. Biomed. Chromatogr. Immunol. 2008. 9: 15.
30. Badovinac, V. P., Haring, J. S., Harty, J. T., Initial T cell receptor transgenic cell precursor frequency dictates critical aspects of the CD8(+) T cell response to infection. Immunity 2007. 26: 827-841.
31. Thompson, L. J., Kolumam, G. A., Thomas, S. and Murali-Krishna, K., Innate inflammatory signals induced by various pathogens differentially dictate the IFN-I dependence of CD8 T cells for clonal expansion and memory formation. J. Immunol. 2006. 177: 1746-1754.
32. López, C. B., Yount, J. S., Hermesh, T. and Moran, T. M., Sendai virus infection induces efficient adaptive immunity independently of type I interferons. J. Virol. 2006. 80: 4538-4545.
33. Luft, T., Pang, K. C., Thomas, E., Hertzog, P., Hart, D. N., Trapani, J. and Cebon, J., Type I IFNs enhance the terminal differentiation of dendritic cells. J. Immunol. 1998. 161: 1947-1953.
34. Le Bon, A. and Tough, D. F., Type I interferon as a stimulus for cross-priming. Cytokine Growth Factor Rev. 2008. 19: 33-40.
35. Zietara, N., Łyszkiewicz, M., Gekara, N., Puchałka, J., Dos Santos, V. A., Hunt, C. R., Pandita, T. K. et al., Absence of IFN-beta impairs antigen presentation capacity of splenic dendritic cells via down-regulation of heat shock protein 70. J. Immunol. 2009. 183: 1099-1109.
36. Groothuis, T. and Neefjes, J., The ins and outs of intracellular peptides and antigen presentation by MHC class I molecules. Curr. Top. Microbiol. Immunol. 2005. 300: 127-148.
37. Borden, E. C., Sen, G. C., Uze, G., Silverman, R. H., Ransohoff, R. M., Foster, G. R. and Stark, G. R., Interferons at age 50: past, current and future impact on biomedicine. Nat. Rev. Drug Discov. 2007. 6: 975-990.
38. Cousens, L. P., Peterson, R., Hsu, S., Dorner, A., Altman, J. D., Ahmed, R. and Biron, C. A., Two roads diverged: interferon alpha/beta- and interleukin 12-mediated pathways in promoting T cell interferon gamma responses during viral infection. J. Exp. Med. 1999. 189: 1315-1328.
39. Dalod, M., Salazar-Mather, T. P., Malmgaard, L., Lewis, C., Asselin-Paturel, C., Briere, F., Trinchieri, G. and Biron, C. A., Interferon alpha/beta and interleukin 12 responses to viral infections: pathways regulating dendritic cell cytokine expression in vivo. J. Exp. Med. 2002. 195: 517-528.
40. Waibler, Z., Anzaghe, M., Konur, A., Akira, S., Muller, W. and Kalinke, U., Excessive CPG 1668 stimulation triggers IL-10 production by cDC that inhibits IFN-alpha responses by pDC. Eur. J. Immunol. 2008. 38: 3127-3137.
41. Chouaib, S., Chehimi, J., Bani, L., Genetet, N., Tursz, T., Gay, F., Trinchieri, G. and Mami-Chouaib, F., Interleukin 12 induces the differentiation of major histocompatibility complex class I-primed cytotoxic T-lymphocyte precursors into allospecific cytotoxic effectors. Proc. Natl. Acad. Sci. USA 1994. 91: 12659-12663.
42. Valenzuela, J., Schmidt, C. and Mescher, M., The roles of IL-12 in providing a third signal for clonal expansion of naive CD8 T cells. J. Immunol. 2002. 169: 6842-6849.
43. Keppler, S. J., Theil, K., Vucikuja, S. and Aichele, P., Effector T-cell differentiation during viral and bacterial infections: Role of direct IL-12 signals for cell fate decision of CD8(1) T cells. Eur. J. Immunol. 2009. 39: 1774-1783.
44. Muller, U., Steinhoff, U., Reis, L. F., Hemmi, S., Pavlovic, J., Zinkernagel, R. M. and Aguet, M., Functional role of type I and type II interferons in antiviral defense. Science 1994. 264: 1918-1921.
45. van den Broek, M. F., Müller, U., Huang, S., Aguet, M. and Zinkernagel, R. M., Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors. J. Virol. 1995. 69: 4792-4796.
46. Caton, M. L, Smith-Raska, M. R. and Reizia, B., Notch-RBP-J signaling controls the homeostasis of CD8-dendritic cells in the spleen. J. Exp. Med. 2007. 204: 1653-1664.
47. Kyburz, D., Aichele, P., Speiser, D. E., Hengartner, H., Zinkernagel, R. M. and Pircher, H., T cell immunity after a viral infection versus T cell tolerance induced by soluble viral peptides. Eur. J. Immunol. 1993. 23: 1956-1962.
48. + T cells to cause immunopathology. J. Exp. Med. 1998. 187: 763-774.